Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Clinical trial NCT07471789 · RECRUITING

Trial details

NCT number: NCT07471789
Sponsor: Gyala Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloblastic Leukaemia Leukemia, T-Cell

Start date: 2026-02-04
Primary completion: 2029-05-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.